Results of chemotherapy using ifosfamide with doxorubicin in advanced breast cancer
β Scribed by Michael Millward; Michael Lind; Lindsey Gumbrell; Angela Robinson; Thomas Lennard; Brian Cantwell
- Publisher
- Springer US
- Year
- 1994
- Tongue
- English
- Weight
- 564 KB
- Volume
- 29
- Category
- Article
- ISSN
- 0167-6806
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Our objective was to assess the efficacy of a standard dose ifosfamide and doxorubicin containing regimen in the treatment of advanced soft tissue sarcomas. Forty consecutive patients with a median age of 35.5 years were treated. Ifosfamide was administered at a dose of 2.5 g/m 2 /day as 72-hour con
Thirty-nine patients with locally advanced breast cancer (T~b.4, N1-3 or inflammatory carcinoma) received 3 cycles of induction chemotherapy with estrogenic recruitment before surgery. The therapeutic regimen consisted of diethylstilbestrol (DES) orally on days 1-3, 5-Fluorouracil + Doxorubicin + Cy